Department of Rheumatology and Immunology, Beijing 12667Anzhen Hospital, Capital Medical University, Beijing, China.
Department of Cardiology, Beijing 12667Anzhen Hospital, Capital Medical University, Beijing, China.
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221121297. doi: 10.1177/10760296221121297.
Takayasu's arteritis (TA) is a chronic inflammation that frequently involves the aorta and its major branches. It has been known that atherosclerosis can occur in some TA patients. This study aimed to identify the risk factors associated with the development of atherosclerosis in TA. This retrospective study enrolled a total of 101 TA patients. All patients were divided into two groups according to the absence or presence of atherosclerosis. Baseline demographic features and clinical characteristics were compared between two groups. A logistic model was applied to determine the risk factors associated with the development of atherosclerosis. Our data suggested that the disease duration of patients in the atherosclerosis group was significantly longer than that of patients in the non-atherosclerosis group [96(18.00, 180.00) versus 48.00(12.00, 111.00) months] ( = .015). In addition, the average age of patients with atherosclerosis was significantly older compared to patients without atherosclerosis [44.00(38.00, 48.00)versus 28.50(24.00,37.00)years] ( .001). Logistic regression analysis showed that the risk of developing atherosclerosis increased by 9.2% per 1 year increase in the disease duration ( = .005, OR 1.092, 95%CI: 1.027-1.162). Patients with TG/HDL-C ratio more than 0.8875 were associated with a 5.861fold increase of risk developing atherosclerosis ( .001, OR 5.861, 95%CI: 2.299-14.939). Our study indicated that prolonged disease duration and elevated TG/HDL-C ratio are associated with the development of atherosclerosis in TA patients.
Takayasu 动脉炎(TA)是一种常累及主动脉及其主要分支的慢性炎症。已知一些 TA 患者可发生动脉粥样硬化。本研究旨在确定与 TA 患者动脉粥样硬化发展相关的危险因素。这项回顾性研究共纳入 101 例 TA 患者。所有患者根据是否存在动脉粥样硬化分为两组。比较两组之间的基线人口统计学特征和临床特征。应用逻辑模型确定与动脉粥样硬化发展相关的危险因素。我们的数据表明,动脉粥样硬化组患者的疾病病程明显长于非动脉粥样硬化组[96(18.00,180.00)与 48.00(12.00,111.00)个月]( = .015)。此外,动脉粥样硬化患者的平均年龄明显大于无动脉粥样硬化患者[44.00(38.00,48.00)与 28.50(24.00,37.00)岁]( .001)。Logistic 回归分析显示,疾病病程每增加 1 年,发生动脉粥样硬化的风险增加 9.2%( = .005,OR 1.092,95%CI:1.027-1.162)。TG/HDL-C 比值大于 0.8875 的患者发生动脉粥样硬化的风险增加 5.861 倍( .001,OR 5.861,95%CI:2.299-14.939)。本研究表明,疾病病程延长和 TG/HDL-C 比值升高与 TA 患者动脉粥样硬化的发生有关。